October 2025

PSYCHIATRY

KETAMINE FOR TREATMENT-RESISTANT DEPRESSION

Featuring: Brandon Hamm, MD

Episode Summary

In this episode of Better Edge, Brandon Hamm, MD, discusses Northwestern Medicine’s evidence-based approach to ketamine therapy, including patient selection, safety protocols, and a newly expanded infusion suite. He compares ketamine with TMS and ECT, addresses common misconceptions, and highlights training opportunities for residents. The episode also previews emerging treatments like vagus nerve stimulation.
 
Clinical impact: This conversation underscores ketamine’s growing role as a safe, effective option within a comprehensive interventional psychiatry framework.
Brandon Hamm, MD, Assistant Professor of Consultation Liaison Psychiatry in the department of Psychiatry and Behavioral Sciences at Northwestern Medicine​

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​

You May Also Like